Intersect Ent (XENT) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 4 254 sessions, May 12, 2021 to May 12, 2022
- Largest daily move
- +11.6% close of August 6, 2021
- 1-year change
- +60.3% closing prices, May 12, 2021 to May 12, 2022
- 5-year change
- +22.3% closing prices, May 12, 2017 to May 12, 2022
Company Description
Intersect Ent (NASDAQ: XENT) is classified in the medical devices industry within the Healthcare sector and carries a market capitalization of $954.9M.
XENT has gained 60.3% over the past year. The last closing price was $28.24.
This page collects what Stock Titan holds for XENT, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Intersect Ent (XENT) closed at $28.24 on May 12, 2022. Over the past 12 months, the price has gained 60.3%.
XENT Metrics & Rankings
Price returns through May 12, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Intersect Ent has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include management, earnings, acquisition, conferences. View all XENT news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
XENT Company Profile & Sector Positioning
Intersect Ent (XENT) operates in the Medical Devices industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing XENT often look at related companies in the same sector, including InMode Ltd. (INMD), iRadimed Corporation (IRMD), Tandem Diabetes Care, Inc. (TNDM), Beta Bionics, Inc. (BBNX), and Establishment Labs Holdings Inc. (ESTA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate XENT's relative position within its industry.